Montreal, Canada

Pallavi Thakur

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cantero Therapeutics, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pallavi Thakur. Retrieved from https://idiyas.com/inventor/pallavi-thakur-5wy912oz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pallavi Thakur

Introduction

Pallavi Thakur is a notable inventor based in Montreal, Canada. She has made significant strides in the field of pharmaceutical sciences, particularly in the development of compounds that address critical health issues.

Latest Patents

Pallavi holds a patent for "Triazole glycolate oxidase inhibitors." This invention provides triazole carboxylic acids and related compounds, as well as pharmaceutically acceptable salts thereof, which are useful as glycolate oxidase inhibitors. The patent also describes pharmaceutical compositions and methods for treating primary hyperoxaluria, type I (PH) and kidney stones.

Career Highlights

Pallavi is currently associated with Cantero Therapeutics, Inc., where she continues to contribute to innovative research and development in the pharmaceutical sector. Her work focuses on creating effective treatments for conditions that significantly impact patients' quality of life.

Collaborations

Pallavi collaborates with esteemed colleagues, including Hans Maag and Miguel Xavier Fernandes, to advance her research and bring new solutions to the market.

Conclusion

Pallavi Thakur's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts highlight her commitment to improving healthcare solutions. Her work exemplifies the impact of dedicated inventors in addressing pressing medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…